Target intelligence / Profile preview

Gingival-derived mesenchymal stem cell proliferation

Molecular classification
Other
01

Overview

Gingival-derived mesenchymal stem cell (GMSC) proliferation refers to the biological process of cell division and population expansion of multipotent stromal cells harvested from the gingival tissue. GMSCs are a unique subpopulation of mesenchymal stem cells known for their easy accessibility, rapid proliferation rate, and potent immunomodulatory properties, which make them attractive candidates for regenerative medicine (Zhang et al., 2009, Journal of Dental Research). This proliferative process is regulated by various endogenous growth factors and signaling pathways, such as the Wnt/beta-catenin and MAPK cascades, which maintain the stemness and self-renewal of the cells (Mao et al., 2017, Stem Cells International). While GMSC proliferation is a critical parameter in developing cell-based therapies for inflammatory and autoimmune conditions, it is a biological phenomenon or cellular readout rather than a discrete molecular target like a receptor or enzyme. In a therapeutic context, researchers may use growth factors such as basic fibroblast growth factor (bFGF) to enhance this proliferation ex vivo to ensure sufficient cell numbers for clinical transplantation (Wang et al., 2011, Journal of Periodontal Research).

Other names
GMSC proliferationGingival mesenchymal stem cell expansionProliferation of gingival multipotent stromal cells
02

Mechanism of action

Not applicable as this is a biological process; however, it is modulated via the activation of mitogenic signaling pathways such as MAPK/ERK and PI3K/Akt to induce cell cycle progression.

03

Biological functions

Cell proliferationTissue regenerationImmunomodulationStem cell self-renewal
04

Disease associations

PeriodontitisWound healingAutoimmune diseaseInflammation
05

Safety considerations

Risk of malignant transformation during extensive ex vivo expansionPhenotypic instabilityPotential for unwanted heterotopic differentiation
06

Interacting drugs

Basic fibroblast growth factor

2 more in the full profile.

07

Biomarkers

Ki-67Proliferating cell nuclear antigen (PCNA)CD90CD73CD105

Beyond the preview

Go deeper on Gingival-derived mesenchymal stem cell proliferation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gingival-derived mesenchymal stem cell proliferation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call